A038070 Stock Overview
A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Seoulin Bioscience Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,250.00 |
| 52 Week High | ₩11,429.04 |
| 52 Week Low | ₩5,988.04 |
| Beta | 1.17 |
| 1 Month Change | 12.86% |
| 3 Month Change | 18.71% |
| 1 Year Change | -2.81% |
| 3 Year Change | -41.33% |
| 5 Year Change | -13.44% |
| Change since IPO | 0.43% |
Recent News & Updates
Recent updates
Concerns Surrounding Seoulin BioscienceLtd's (KOSDAQ:038070) Performance
Mar 25
Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement
Dec 04Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why
May 03Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 13Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year
Feb 15Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?
Jan 20
Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend
Dec 25Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Dec 06Shareholder Returns
| A038070 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 6.0% | 4.3% | 3.9% |
| 1Y | -2.8% | 23.8% | -1.3% |
Return vs Industry: A038070 underperformed the KR Biotechs industry which returned 23.8% over the past year.
Return vs Market: A038070 underperformed the KR Market which returned -1.3% over the past year.
Price Volatility
| A038070 volatility | |
|---|---|
| A038070 Average Weekly Movement | 9.0% |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in KR Market | 12.4% |
| 10% least volatile stocks in KR Market | 3.0% |
Stable Share Price: A038070's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A038070's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 104 | Eul-Moon Hwang | www.seoulin.co.kr |
Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd.
Seoulin Bioscience Co.,Ltd. Fundamentals Summary
| A038070 fundamental statistics | |
|---|---|
| Market cap | ₩71.25b |
| Earnings (TTM) | ₩2.73b |
| Revenue (TTM) | ₩74.57b |
Is A038070 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A038070 income statement (TTM) | |
|---|---|
| Revenue | ₩74.57b |
| Cost of Revenue | ₩55.85b |
| Gross Profit | ₩18.72b |
| Other Expenses | ₩16.00b |
| Earnings | ₩2.73b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 315.69 |
| Gross Margin | 25.11% |
| Net Profit Margin | 3.66% |
| Debt/Equity Ratio | 0.5% |
How did A038070 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/31 03:05 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Seoulin Bioscience Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sung Hwan Choi | Kyobo Securities Co., Ltd |
| Ju-Hong Choe | LS Securities Co., Ltd. |
| Seung Kim | SK Securities Co., Ltd. |